(Q40277321)

19 September 2017

An artificial neural network approach to the drug efficacy of interferon treatments (English)

1 reference

artificial neural network

19 September 2017

1 reference

Eugene Lin

1

1 reference

19 September 2017

Yuchi Hwang

2

1 reference

19 September 2017

Shu-Ching Wang

3

1 reference

19 September 2017

Z John Gu

4

1 reference

19 September 2017

Ellson Y Chen

5

1 reference

19 September 2017

1 October 2006

1 reference

19 September 2017

1 reference

19 September 2017

7

1 reference

19 September 2017

1017-1024

1 reference

19 September 2017

7

1 reference

Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection

19 September 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

21 January 2018

Therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Introduction to backpropagation neural network computation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Application of neural networks to pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Neural network analysis in pharmacogenetics of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Feedback stabilization using two-hidden-layer nets.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.7.1017

10.2217/14622416.7.7.1017

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference